Effective and safe contraceptive methods not only prevent unplanned pregnancies and their termination, but also make it possible to fully restore the mother's body after surgery to carry out the necessary pre-pregnancy preparation. The goal of the study was to evaluate the clinical outcome of postplacental administration of Cu T 380 A in women during a caesarean section. The study was conducted at Samarkand Maternity Hospital No. 2 to assess the clinical outcome of postplacental administration of Cu T 380 A in women during caesarean section. The present study showed that there were no serious complications and only minor side effects such as pain, fever, bleeding and irregular bleeding, which were observed only in some women during the hospital stay and the control visit in the first 6 months. The determination of vaginal BMW tendrils was made possible in 72.12% of women during the control visit after 6 weeks. The visibility of the tendrils increased over time and after 6 months they were seen in 90.81% of cases. Exposure frequency was 2 cases (4%) and another 2 women (4%) required removal of the PMTCT for various reasons, resulting in a 92.3% retention rate six months after contraception. No cases of pregnancy were registered. Post-placental introduction of BIC Cu T 380 A during a C-section is a practical, convenient, safe, effective and acceptable contraceptive method.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.